Magnetic bead RT-PCR: Establishment of a new method for detecting circulating melanoma cells

Melanoma Research

Volumn 12, Issue 4, 2002, Pages 309-317

  Georgieva, J ^a   Milling, A ^a   Orfanos, C E ^a   Geilen, C C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Magnetic beads; Mart 1; Melanoma; RT PCR; Tyrosinase

Indexed keywords

CD45 ANTIGEN; MELAN A; MELANOMA ANTIGEN; MONOCLONAL ANTIBODY; OLIGODEOXYTHYMIDYLIC ACID; THYMIDINE PHOSPHATE; UNCLASSIFIED DRUG; CD4 ANTIGEN; MART1 ANTIGEN; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; MESSENGER RNA; MICROSPHERE; OLIGO (DT); OLIGODEOXYRIBONUCLEOTIDE; RNA; TUMOR ANTIGEN; TUMOR PROTEIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKOPENIA; MALE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; BLOOD; CANCER STAGING; CELL CULTURE; COMPARATIVE STUDY; EVALUATION; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; TUMOR EMBOLISM;

ADULT; AGED; ANTIGENS, CD4; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOMAGNETIC SEPARATION; MALE; MELANOMA; MICROSPHERES; MIDDLE AGE; NEOPLASM CIRCULATING CELLS; NEOPLASM PROTEINS; NEOPLASM STAGING; OLIGODEOXYRIBONUCLEOTIDES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; ANTIGENS, NEOPLASM; HUMANS; MIDDLE AGED;

EID: 0036021001     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200208000-00002     Document Type: Article

References (37)

1. Melanoma epidemiology
2. Relationship between disease-free interval and survival in patients with recurrent melanoma
3. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
4. Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma
5. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: Evaluation strategy and correlation with known prognostic markers in 123 melanoma patients
6. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions
7. A two center analysis on 238 melanoma patients for detection of circulating tumour cells by RT-PCR for melanoma associated genes
8. Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrence from melanoma
9. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: A quality control study using real-time quantitative RT-PCR
10. Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas
11. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: Use in the characterization of the human melanoma antigen MART-1
12. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases
13. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: A comparison with the whole blood guanidinium isothiocyanate RNA isolation method
14. Increased sensitivity, for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction
15. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma
16. Detection of circulating neoplastic cells by reverse transcriptase-polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis
17. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study
18. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression
19. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma
20. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells
21. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours
22. Stellungnahme und empfehlungen der kommission malignes melanom der DDG zur diagnostik, behandlung und nachsorge des malignen melanoms
23. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas
24. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients
25. Immunobead-PCR: A technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction
26. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients
27. Review: Polymerase chain reaction detection of micrometastases and circulating tumor cells: Application to melanoma, prostate, and thyroid carcinomas
28. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection
29. Immunobead RT-PCR: A sensitive method for detection of circulating tumor cells
30. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction
31. 33 Increased sensitivity in the detection of circulating prostatic tumor cells in peripheral blood after immunobead enrichment and RT-PCR for prostate specific membrane antigen (PSMA) mRNA
32. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood
33. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro
34. Identification and characterization of circulating prostate carcinoma cells
35. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics
36. Detection of circulating melanoma cells by immunomagnetic cell sorting
37. Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: A sensitive method for monitoring purging efficiency